Normal-tension glaucoma: Is it different from primary open-angle glaucoma?

Current Opinion in Ophthalmology

Volumn 19, Issue 2, 2008, Pages 85-88

  Shields, M Bruce ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Intraocular pressure; Normal tension glaucoma; Ocular blood flow; Primary open angle glaucoma

Indexed keywords

BRIMONIDINE; CALCIUM CHANNEL BLOCKING AGENT; TIMOLOL;

BLOOD FLOW; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; GLAUCOMA; HEMATOLOGIC DISEASE; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; NEUROPROTECTION; OCULAR BLOOD VESSEL; OPEN ANGLE GLAUCOMA; OPTIC DISK; PATIENT CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VISUAL FIELD;

GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; OPTIC DISK; OPTIC NERVE DISEASES; REGIONAL BLOOD FLOW; RISK FACTORS;

EID: 40049112112     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3282f3919b     Document Type: Review

References (11)

1. Iwase A, Suzuke Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 2004; 111:1641-1648.
2. Martus P, Stroux A, Budde WM, et al. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma. Am J Ophthalmol 2005; 139:999-1009.
3. Kim DM, Seo JH, Kim SH, Hwang S-S. Comparison of localized retinal nerve fiber layer defects between a low-teen intraocular pressure group and a highteen intraocular pressure group in normal-tension glaucoma patients. J Glaucoma 2007; 16:293-296.
4. Greenfield DS, Liebmann JM, Ritch R, Krupin T, et al. Visual field and intraocular pressure asymmetry in the Low-Pressure Glaucoma Treatment Study. Ophthalmology 2007; 114:460-465. The Low-Pressure Glaucoma Treatment Study, which randomizes NTGpatients into treatment with either brimonidine tartrate 0.2% or timolol maleate 0.5%, may shed light on the relative merits of the two drugs in this population, and is also providing a better understanding of the disorder and its response to IOP-lowering therapy.
5. Collaborative Normal-Tension Glaucoma Study Group. Natural history of normal-tension glaucoma. Ophthalmology 2001; 108:247-253.
6. Barkana Y, Anis S, Liebmann J, et al. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol 2006; 124:793-797.
7. Kiuchi T, Motoyama Y, Oshika T. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma. Ophthalmology 2006; 113:2150-2155.
8. Kurita N, Tomidokoro A, Mayama C, et al. No apparent association between ocular perfusion pressure and visual field damage in normal-tension glaucoma patients. Jpn J Ophthalmol 2006; 50:547-549.
9. Tokunaga T, Kashiwagi K, Tsumura T, et al. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma and normal-tension glaucoma. Jpn J Ophthalmol 2004; 48:380-385.
10. Leibovitch I, Kurtz S, Kesler A, et al. C-reactive protein levels in normal tension glaucoma. J Glaucoma 2005; 14:384-386.
11. Suzuki J, Tomidokoro A, Araie M, et al. Visual field damage in normal-tension glaucoma patients with or without ischemic changes in cerebral magnetic resonance imaging. Jpn J Ophthalmol 2004; 48:340-344.